SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RT who wrote (5578)2/21/1998 12:05:00 PM
From: DR. BOND  Read Replies (2) of 23519
 
RT....One possible explanation for why refills do not exceed new scripts is that most refills are at the 1,000 mg dosage (which is in great demand and short supply) while most new scripts are at the 250 and 500 mg level, where their is more availability of product.

But for an exact answer, please allow me to ask my contacts at VVUS and on the St. and I will report back late monday or tuesday.

Thanx,

DB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News